CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Enanta Pharmaceuticals Advances RSV Drug to Phase 2/3 Trial After US FDA Meeting

Phase 2Positive
AI Analysis

Summary

Enanta Pharmaceuticals has advanced its RSV drug candidate to Phase 2/3 trial following a meeting with the US FDA.

Clinical Trial Data

Phase

2/3

Importance:5/10
Sentiment:
0.50
clinical developmentRSVPhase 2/3FDA meeting
Related Companies

Read the original article

Published by yahoo_finance on June 18, 2026 11:41 AM

Read Original